Cartesian Therapeutics (RNAC) Revenue (2015 - 2026)
Cartesian Therapeutics' (RNAC) quarterly Revenue came in at $78000.0 in Q1 2026, down 92.91% year-on-year from $1.1 million in Q1 2025, and down 91.76% on a QoQ basis from $947000.0 in Q4 2025.
Cartesian Therapeutics (RNAC) Revenue (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 12 years of Revenue data on file, last reported at $78000.0 in Q1 2026.
- On a quarterly basis, Revenue fell 92.91% year-over-year to $78000.0 in Q1 2026; TTM through Mar 2026 was $1.0 million, a 96.94% decrease from a year earlier, with the FY2025 full-year figure at $2.8 million, down 92.69% from the prior year.
- Revenue for Q1 2026 stood at $78000.0, down from $947000.0 in the prior quarter.
- Over the last five years, Revenue for RNAC reached as high as $39.3 million in Q2 2022 and fell as low as -$836000.0 in Q4 2024.
- Historically, Revenue has averaged $12.7 million across 5 years, with a median of $6.2 million in 2023.
- On a YoY basis, Revenue climbed as much as 533.85% in 2024 and fell as far as 110.11% in 2024.
- Year by year, Revenue stood at $16.8 million in 2022, then plunged by 50.78% to $8.3 million in 2023, then sank by 110.11% to -$836000.0 in 2024, then surged by 213.28% to $947000.0 in 2025, then slumped by 91.76% to $78000.0 in 2026.
- Per Business Quant data, the three most recent Revenue figures were $78000.0 in Q1 2026, $947000.0 in Q4 2025, and $1.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Cartesian Therapeutics | 210.28 Mn | 210.28 Mn | - | 78,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78,000.00 |
| Dec 31, 2025 | 947,000.00 |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | -836,000.00 |
| Jun 30, 2024 | 33.27 Mn |
| Mar 31, 2024 | 5.84 Mn |
| Dec 31, 2023 | 8.27 Mn |
| Sep 30, 2023 | 6.55 Mn |
| Jun 30, 2023 | 5.25 Mn |
| Mar 31, 2023 | 5.94 Mn |
| Dec 31, 2022 | 16.80 Mn |
| Sep 30, 2022 | 20.71 Mn |
| Jun 30, 2022 | 39.27 Mn |
| Mar 31, 2022 | 34.00 Mn |
| Dec 31, 2021 | 29.94 Mn |
| Sep 30, 2021 | 24.43 Mn |
| Jun 30, 2021 | 19.66 Mn |
| Mar 31, 2021 | 11.05 Mn |
| Dec 31, 2020 | 11.95 Mn |
| Sep 30, 2020 | 4.65 Mn |